The purpose of the present study was to characterize different -adrenoceptors (-ARs) and determine their role in the spontaneously tonic smooth muscle of the internal anal sphincter (IAS). ]iodocyanopindolol to -AR subtypes revealed the presence of a high-affinity site (K d1 ϭ 96.4 Ϯ 8.7 pM; B max1 ϭ 12.5 Ϯ 0.6 fmol/mg protein) and a low-affinity site (K d2 ϭ 1.96 Ϯ 1.7 nM; B max2 ϭ 58.7 Ϯ 4.3 fmol/mg protein). Competition binding with selective -AR antagonists revealed that the high-affinity site correspond to  1 / 2 -AR and the low affinity site to  3 -AR. Receptor binding data suggest the predominant presence of  3 -AR over  1 / 2 -AR. Western blot studies identified  1 -,  2 -, and  3 -AR subtypes. The presence of  1 -,  2 -, and  3 -ARs was further demonstrated by mRNA analysis using RT-PCR. The studies demonstrate a comprehensive functional and molecular characterization of  1 -,  2 -, and  3 -ARs in IAS smooth muscle. These studies may have important implications in anorectal and other gastrointestinal motility disorders.It is well known that postjunctional -adrenoceptors (-ARs) mediate the inhibitory effects of sympathetic nerve stimulation in different smooth muscles including those of the gastrointestinal tract (Manara et al., 1995b;Gauthier et al., 2000). The intestinal -AR was originally described as a  1 -and  2 -AR (Lands et al., 1967). Further studies with gastrointestinal preparations from several species established the relaxant effect of classical -AR ( 1 and  2 ) agonists (Bennett, 1965;Hedges and Turner, 1969;De Ponti et al., 1996a). Subsequently, studies investigating -ARs in gastrointestinal smooth muscle from several species demonstrated relaxation responses that were resistant to propranolol and displayed lower affinity to other conventional -AR antagonists (Arch and Kaumann, 1993;Goldberg and Frishman, 1995;Strosberg, 1997;Manara et al., 2000). This finding, along with the emergence of a new class of -AR agonists described first in adipocytes (Feve et al., 1991), suggested the presence of an "atypical" class of -ARs. In 1989, Emorine et al. (1989) cloned and sequenced  3 -AR and found that it shared the pharmacological characteristics of the atypical -AR.The  3 -AR has been found in a variety of mammalian tissues (Berkowitz et al., 1995) including white and brown adipocytes (Muzzin et al., 1991), trachea (Webber and Stock,